Vale, Rozenee S.
HRN: 02-37-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2023
CEFUROXIME 1.5GM (VIAL)
02/04/2023
02/04/2023
IV
1.5g
1 Hour Prior OR
Thyroid Mass
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes